Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 10, 2001, Pages 625-630

  Gude, Rajiv P ^a   Binda, Mercedes M ^b   Boquete, Alejandra L ^b   Bonfil, Daniel R ^b  

^a CANCER RESEARCH INSTITUTE   (India)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Angiogenesis; Antiangiogenic factor(s); B16 F10; Melanoma; Pentoxifylline

Indexed keywords

METALLOPROTEINASE; PENTOXIFYLLINE; UROKINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENDOTHELIUM CELL; FEMALE; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION; TUMOR VOLUME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 84988267441     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320100262     Document Type: Article

References (29)

1. Studies on tumor induced angiogenesis
2. Pentoxifylline inhibits hypoxia induced upregulation of tumor cell tissue factor and vascular endothelial growth factor
3. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus
4. Mechanisms of drug resistance
5. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
6. Antiangiogenesis and apoptosis as mediators of concomitant tumor resistance induced by Calu-6, a human lung carcinoma cell line, in nude mice
7. Slower tumor growth due to caloric restriction does not imply improved survival
8. Enhancement of apoptosis in irradiated glioblastoma cells by pentoxifylline
9. Isolation and characterization of cerebral resistance vessel endothelium in culture
10. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline
11. Selection of successive tumor lines for metastasis
12. Fighting cancer by attacking the blood supply
13. Human endothelial cells in culture, growth and DNA synthesis
14. Inhibition of lung homing of B16-F10 by pentoxifylline, a microfilament depolymerising agent
15. Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline
16. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
17. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
18. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
19. Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents
20. Investigation of tumor angiogenesis in an id mouse model: Role of host tumor interactions
21. The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro) urokinase in cultures of normal human kidney cells
22. Pentoxifylline, a biomedical profile
23. A hemangioendothelioma-derived cell line: Its use as a model for the study of endothelial cell biology
24. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells
25. Distribution and metabolism of pentoxifylline in non-tumor bearing mice
26. Treating cancer by inhibiting angiogenesis: New hopes and potential pitfalls
27. Pentoxifylline
28. Macrophages and angiogenesis
29. Matrilysin